Possible Sanctions For Takeda In Actos Bladder Cancer MDL
By Greg Ryan (January 29, 2014, 8:41 PM EST) -- A Louisiana federal judge has found that Takeda Pharmaceuticals America Inc. breached a duty to preserve evidence in multidistrict litigation claiming its anti-diabetic drug Actos causes bladder cancer, saying she would decide what sanctions are warranted during a bellwether trial starting Monday.
Takeda put a litigation hold on documents and electronic data related to Actos in 2002, yet repeatedly destroyed emails and other documents with information about the drug over much of the next decade, U.S. District Judge Rebecca Doherty ruled in a 75-page opinion on Jan. 27.
The documents Takeda destroyed are relevant to the plaintiffs' claims and would likely...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!